CytoTools AG
XETRA:T5O
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CytoTools AG
XETRA:T5O
|
DE |
|
Far Eastern Department Stores Ltd
TWSE:2903
|
TW |
|
Nitto Fuji Flour Milling Co Ltd
TSE:2003
|
JP |
|
PDG Realty SA Empreendimentos e Participacoes
BOVESPA:PDGR3
|
BR |
|
Vardhman Acrylics Ltd
NSE:VARDHACRLC
|
IN |
|
Yusin Holding Corp
TWSE:4557
|
TW |
|
Hubei Sanxia New Building Materials Co Ltd
SSE:600293
|
CN |
|
Moderna Inc
NASDAQ:MRNA
|
US |
|
EssilorLuxottica SA
PAR:EL
|
FR |
|
Descartes Systems Group Inc
TSX:DSG
|
CA |
|
Rane Brake Linings Ltd
NSE:RBL
|
IN |
|
Apollo Tourism & Leisure Ltd
ASX:ATL
|
AU |
|
NervGen Pharma Corp
XTSX:NGEN
|
CA |
|
Steel Connect Inc
NASDAQ:STCN
|
US |
|
Halcyon Agri Corporation Ltd
SGX:5VJ
|
SG |
|
L
|
Lion Rock Resources Inc
XTSX:ROAR
|
CA |
|
D
|
Dhunseri Ventures Ltd
NSE:DVL
|
IN |
|
H
|
HB Technology Co Ltd
KOSDAQ:078150
|
KR |
|
Z
|
Zamet SA
WSE:ZMT
|
PL |
|
C
|
ChipMOS Technologies Inc
TWSE:8150
|
TW |
|
Asia Vital Components Co Ltd
TWSE:3017
|
TW |
|
Ssangyong Motor Co Ltd
KRX:003620
|
KR |
|
S
|
Steakholder Foods Ltd
NASDAQ:STKH
|
IL |
|
N
|
NHN Bugs Corp
KOSDAQ:104200
|
KR |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of T5O.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
T5O Competitors Multiples
CytoTools AG Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
C
|
CytoTools AG
XETRA:T5O
|
19.4m EUR | 945.9 | -29.4 | -27.5 | -26.7 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.5B USD | 6 | 88 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.7B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.5B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.2B USD | 9.3 | 28.4 | 21.3 | 22.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.7B USD | 5.6 | 17.7 | 13.1 | 15 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.9B EUR | 12.4 | 39.7 | 43.1 | 44 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD | 2.9 | 32.4 | 10.9 | 13.7 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |